Source: CureToday articles
Dr. Neha Mehta-Shah shares how patients can better understand their subtype of rare lymphoma, as well as expands on the challenges these patients face.
Recent Content
- An Expert Offers Advice and Resources for Navigating Rare Lymphoma
- Trial Data Show Long-Term Safety, Efficacy of Xanomeline/Trospium for Schizophrenia
- Celebrating an Expert at Emotional Support
- Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myeloma
- Dr. Eng Breaks Down Braftovi Plus Erbitux FDA Approval in BRAF+ mCRC
- Research Identifies Need for Increased Evidence-Based Use of Buspirone
- A Healer’s Touch During My Experience With Cancer Care
- Single Dose of Xofluza Reduces Odds of Untreated Household Members Contracting Influenza
- Ferritin-NP-preS1 Therapeutic Vaccine With siRNA Shows Durable Effects in CHB
- Medically Integrated Pharmacies: The Role of Limited Distribution Networks in Advancing Modern Oncology Pharmacy